Monday, May 2, 2016

BRIEF-Nivalis Therapeutics reports Q1 loss per share $0.51

* Nivalis therapeutics reports first quarter 2016 financial

results

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)